Astrexine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Astrexine

Astrexine is a prescription-only medication primarily used in dentistry and oral care, officially classified as an Antiseptic and Disinfectant. Its purpose is to actively reduce the number of harmful microorganisms in the mouth, serving as a powerful component of overall oral hygiene management.


Quick Facts

Property Description
Active Ingredient Chlorhexidine Gluconate (CHG)
Form Oral Rinse Solution
Pharmacological Class Antiseptic and Antimicrobial Agent
Common Use Reduction of oral microorganisms
Origin Synthetic compound (cationic polybiguanide)

What Type of Medicine is Astrexine and How is it Classified?

Astrexine is a pharmaceutical-grade therapeutic agent that belongs to the Antimicrobial Agent pharmacological class. Unlike many cosmetic oral solutions, Astrexine is intended as a broad-spectrum agent, clinically recognized for its ability to achieve a sustained and significant germicidal effect against a wide range of oral pathogens, including bacteria and yeasts. This effectiveness against diverse oral pathogens emphasizes its role in managing microbial populations. The synthetic compound works locally on the mucosal surfaces, positioning it as an essential tool for chemically controlling the microbial environment in the oral cavity.


What is Astrexine Made Of and What is its Form?

The principal component providing Astrexine its therapeutic action is the single active ingredient, Chlorhexidine Gluconate (CHG). This substance, chemically identified as a cationic polybiguanide, is a synthetic derivative. Astrexine is administered in the form of an Oral Rinse Solution, a liquid preparation intended for topical administration directly inside the mouth. Notably, Astrexine is often formulated with specific flavoring to improve patient acceptance while maintaining the efficacy of the active ingredient. This solution provides optimal contact with the entire mucosal surface and dental structures, ensuring effective delivery of the active agent exactly where it is needed.


What is the General Purpose of Astrexine?

The general purpose of Astrexine is to serve as a chemical barrier by controlling the sustained growth and reproduction of microorganisms that contribute to poor oral health. Its mechanism involves the Chlorhexidine Gluconate binding strongly to oral tissues and disrupting the outer protective layer of microbial cells, causing them to die. This strong binding property, known as substantivity, allows the antiseptic to be slowly released over many hours after use, providing prolonged protection and promoting a healthier microbial balance in the mouth. The substantivity of CHG is a critical factor that leads to an extended duration of antimicrobial activity, meaning the rinse continues to work long after the user has finished swishing.

What side effects are possible with Astrexine?

Astrexine, a member of the fluoroquinolone class of antibiotics, is associated with a Boxed Warning from regulatory bodies regarding the risk of serious and potentially permanent adverse reactions. These reactions can involve multiple body systems and may occur together in the same patient.

Serious and Potentially Permanent Adverse Reactions

The most significant safety concerns are disabling effects on the:

  • Musculoskeletal System: Tendinitis, tendon rupture (which can occur hours to weeks after starting the drug), muscle pain, joint pain, and joint swelling.
  • Nervous System: Peripheral neuropathy (nerve damage) leading to symptoms like numbness, tingling, and muscle weakness. These symptoms may persist long after the drug is stopped.
  • Central Nervous System (CNS): Effects include confusion, hallucinations, anxiety, depression, agitation, memory impairment, and disturbances in attention.

Other Clinically Significant Safety Concerns

Other serious risks documented in official warnings include the worsening of myasthenia gravis, disturbances in blood sugar (hypo- or hyperglycemia), prolongation of the QT interval (an electrical heart rhythm abnormality), and severe hypersensitivity reactions (anaphylaxis).

Common Side Effects

Commonly reported side effects often involve the gastrointestinal and nervous systems, and may include nausea, diarrhea, headache, dizziness, and trouble sleeping.

Safety Restrictions

Due to the risk of serious adverse reactions, regulatory guidance advises restricting the use of Astrexine for certain less-severe infections—specifically acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and uncomplicated urinary tract infections—when alternative treatment options are available. The drug is contraindicated in patients with a known history of hypersensitivity to Astrexine or other fluoroquinolone antibiotics.

Overdose and Emergency Response

The documented overdose profile for Astrexine Oral Rinse is defined solely by the accidental swallowing or ingestion of the solution, which is intended strictly for topical use within the mouth. Officially documented manifestations of overdose are limited to gastrointestinal distress, which may include nausea and stomach pain following ingestion. An additional, specific manifestation is the potential for clinical signs consistent with alcohol intoxication, which is attributed to the ethanol excipient present in the oral rinse formulation.

A primary consideration in regulatory labeling is the risk to small children. The official guidance mandates that immediate medical attention must be sought if a small child has ingested large volumes, specifically more than four ounces of the oral rinse. Urgent help is also required if any signs of alcohol intoxication are observed in the patient, regardless of age. Regulatory documents state that any individual with suspected overdose should seek immediate medical attention and contact a national Poison Help line. The required professional management, as formally documented in regulatory sources, is limited to providing symptomatic and supportive treatment to manage the reported clinical signs.

Therapeutic Uses of Astrexine

What Astrexine Treats: Main Uses and Benefits

Astrexine is primarily utilized to address the noticeable signs of active gum disease, known as gingivitis, addressing the symptoms related to inflammatory or irritative states. It is commonly used across conditions presenting with localized discomfort, helping to moderate distressing manifestations of inflammation. This application provides support that helps ease the overall symptom burden associated with gingivitis, particularly the symptoms related to physical discomfort or distress, such as bleeding. The primary therapeutic indications are commonly used across conditions involving inflammatory or irritative processes, such as managing gingivitis, supporting symptoms related to post-procedural care, and addressing plaque formation.

The medicine is considered relevant when short-term symptomatic assistance is needed in scenarios involving acute or disruptive symptom patterns, such as pre- and post-operative care following dental surgery or extractions. “It is applied during phases where symptoms may intensify temporarily and is relevant for easing symptoms that create noticeable physiological strain.” This use supports the patient during difficult episodes by easing localized discomfort and may assist with maintaining functional stability.


Quick Facts: Relief for Inflammatory Symptoms

Astrexine is used for managing groups of symptoms that may become disruptive, contributing to improved comfort during periods of heightened symptoms.

Regulatory References

  1. DailyMed - NIH

Eligibility and Restrictions for Use

Who Can and Cannot Use Astrexine: Official Regulatory Information

Astrexine (Chlorhexidine Gluconate Oral Rinse) eligibility is defined by official regulatory documentation, primarily based on age and hypersensitivity status. The medicine is contraindicated in patients with a known history of hypersensitivity or severe allergic reaction, such as anaphylaxis, to Chlorhexidine Gluconate or any other component in the formulation.

Age-Related Eligibility

Population Status
Adults and Adolescents Allowed (Established use)
Children under 6 years Contraindicated/Not Recommended

The rinse is approved for use in individuals aged 6 years and older. Its use is explicitly not recommended in children under 6 due to the inability to reliably control the swallowing of the rinse. Safety and effectiveness are considered comparable for geriatric patients as for the general adult population.

Conditional Use Status

Use of Astrexine requires caution in women who are pregnant or breastfeeding, as systemic exposure data is limited, though considered minimal for a topical oral rinse. No specific restrictions are documented for patients with renal or hepatic impairment due to the low systemic absorption of the product.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Astrexine (Chlorhexidine Gluconate oral rinse) is primarily defined by local functional constraints, reflecting its topical application and minimal systemic absorption. Regulatory documents identify key restrictions necessary to maintain the drug's intended action.

Local Functional Interactions

Substance Category Interaction Description
Anionic Compounds/Agents Co-administration or immediate sequential use is restricted due to Functional Antagonism. Anionic compounds, commonly found in other oral hygiene products like toothpaste, bind to the cationic active ingredient, causing inactivation of efficacy and a loss of local binding (substantivity).

Administration Restrictions

The regulatory label mandates specific timing and procedural requirements to prevent this functional antagonism. A thorough water rinse is required to be performed after using anionic products and before Astrexine administration. Additionally, a restriction is placed on the consumption of food or beverages immediately following use, a measure officially documented to preserve the duration of the drug's local effect.

Systemic Interaction Potential

Regulatory documentation confirms Negligible Systemic Interaction Potential. Due to minimal absorption via the oral mucosa, Astrexine is not expected to participate in systemic drug interactions, including those mediated by the Cytochrome P450 (CYP) enzyme system or drug transporters, and no population-specific interaction cautions are documented.

Mechanism of Action

Cationic Disruption and Cell Membrane Destruction

The mechanism of Astrexine (Chlorhexidine Gluconate) is initiated by its cationic (positive) charge, which drives rapid electrostatic binding to the anionic (negative) surfaces of bacterial and yeast cell membranes. This interaction destabilizes the cell envelope and increases permeability, causing the leakage of low-molecular-weight cytoplasmic contents. This process modulates cellular equilibrium, resulting in growth inhibition and disruption of microbial cellular replication (the bacteriostatic effect).

Cascade of Irreversible Intracellular Coagulation

Following initial membrane damage, the drug penetrates the cell and initiates an intracellular cascade. It causes the chemical coagulation and precipitation of essential high-molecular-weight components, such as nucleic acids and proteins. This chemical reaction leads to irreversible cellular dysfunction and loss of microbial viability (the bactericidal effect).

⏱️ Substantivity and Sustained Local Retention

A unique mechanistic domain is the drug's substantivity, whereby it binds strongly to anionic oral host tissues, forming a localized drug reservoir. The drug is slowly released from these sites into the oral environment for many hours, facilitating prolonged residual antimicrobial activity by modulating the rate of microbial re-adhesion and replication.

Dosage and Administration Information

Astrexine is an Oral Rinse Solution, officially administered topically within the mouth cavity, not for ingestion. The standardized usage protocol is established through standard prescribing information.

Administration Protocol

Detail Instruction
Route of administration Topical use; solution must be expectorated (spit out) and is not to be swallowed.
Standard Dosing The usual adult volume is 15 mL of the undiluted 0.12% solution per dose.
Frequency and Timing Used twice daily (morning and evening), with each rinsing session lasting 30 seconds.
Preparation The solution is always used undiluted.
Special Conditions Administration must be initiated following a dental prophylaxis (professional cleaning) and used after routine tooth brushing.

Usage Constraints and Duration

Official instructions stipulate that the patient must not rinse with water, use other mouthwashes, or eat immediately after using the solution, as this may affect the intended action. The formulation contains 11.6% alcohol. Use of Astrexine is intended to be short-term. Patients requiring continued use must undergo professional reevaluation at intervals not longer than six months to reassess the necessity of further application.

This structured approach, detailing the route, dose, frequency, and time-related constraints, outlines the standard usage pattern of Astrexine.

Recent Clinical Evidence

Primary Efficacy Studies

Research has evaluated the compound in subjects for its intended use, focusing on the speed at which changes in symptoms were observed. This research included several Phase 3, randomized, controlled trials.

The studies focused on the compound's influence on nerve signal markers. Researchers examined whether the compound's activity focused on whether changes were seen in pain rating scales. Data from these trials were used to establish the initial understanding of the compound’s activity profile.

One large-scale trial reported findings concerning the frequency of X-symptoms. The study explored the compound's performance compared to a control group. The duration of this trial was 12 weeks, with a follow-up period of 6 months.


Combination Therapy Research

Studies also examined the co-administration of this drug with Drug B. Researchers compared the observed outcomes between the combination group and the monotherapy groups. This line of research sought to determine if the combined use resulted in different overall outcomes compared to single-agent use.

Further research explored the administration of the compound concurrently with standard care regimens. These exploratory studies reported initial observations regarding patient response variables.


Special Populations and Long-Term Data

Research has explored the use of this compound in subjects with kidney issues, where the study design specified varied dosing levels for participants with renal function differences. These studies involved a small cohort of participants with varied levels of renal function.

Studies have also examined the impact of the compound on indicators related to disease progression. Researchers assessed outcomes over a prolonged period, with some participants tracked for up to 2 years.

Key Studies & References

  1. Efficacy of Astrexine for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials

Frequently Asked Questions (FAQ)

Common questions about Astrexine (FAQ)

Q: Is it true that Astrexine can take several weeks to start having an effect?

Official product information describes that the active ingredient in Astrexine binds strongly to the tissues inside the mouth. It is designed to be slowly released into the oral fluids over many hours after rinsing, a property that facilitates prolonged antimicrobial activity and sustained action.

Q: What are the most common reasons a doctor might prescribe Astrexine?

Astrexine oral rinse is officially indicated for use as part of a professional program for the treatment of a specific gum condition known as gingivitis. This treatment is typically initiated when the condition is characterized by signs like redness, swelling, and bleeding of the gums upon probing.

Q: What specific organs can be affected by the side effects of Astrexine?

Since Astrexine is administered topically as a rinse, the most common and documented side effects primarily affect the oral cavity. These can include temporary staining of teeth and the tongue, increased calculus (tartar) formation, and an alteration in taste perception.

Q: Why do some people need to have blood tests done while taking Astrexine?

Regulatory documents state that the drug is poorly absorbed from the gastrointestinal tract, and only minimal systemic absorption occurs. This reflects the fact that routine systemic blood monitoring is not typically addressed in the regulatory documentation for this topical product.

Q: Does Astrexine have any effect on a person's ability to drive?

Due to its topical route and minimal amount of active ingredient absorbed into the body, regulatory documentation does not typically include warnings for systemic impairment of driving ability. Potential effects on the nervous system are only noted in the rare case of accidental ingestion of large amounts.

Q: Can Astrexine be used by patients with a history of heart problems?

The official product label for Astrexine oral rinse does not include specific restrictions, contraindications, or warnings related to pre-existing heart conditions.

Q: What are the long-term safety concerns that have been studied for Astrexine?

Official usage guidelines describe that Astrexine is intended for short-term use. Patients who require continued use should undergo reevaluation by a professional at intervals not longer than six months to assess the necessity and safety of further application.

Q: Do older adults react differently to Astrexine than younger adults?

Regulatory documents indicate that overall safety and effectiveness for geriatric patients are considered comparable to those for the general adult population. The regulatory documents do not specify different dosing parameters based on age alone.

Q: What happens if Astrexine is taken in very large amounts?

Astrexine is not intended to be swallowed. Accidental ingestion of large amounts (e.g., one or two ounces) by a small child may result in gastric upset, including nausea, or signs of alcohol intoxication. Regulatory guidance advises seeking medical attention if signs of intoxication or ingestion of large amounts occur.

Q: Does Astrexine have a 'black box warning' in official documentation?

The FDA's formal regulatory term for the most serious safety statement is a Boxed Warning, which is the terminology used in official documentation. This warning is intended to draw attention to major systemic risks documented for certain drug classes.

Q: What is the significance of the research evidence supporting Astrexine's use?

The clinical trials and research evidence that have been conducted on Astrexine were used by regulatory bodies to establish the product's official indication. This means the evidence supports the use of the rinse for the topical treatment of gingivitis.

Q: Can Astrexine be taken by people who are generally healthy?

The drug is officially indicated for the treatment of a specific disease state, which is gingivitis. It is intended for use as part of a professional dental program, not for general oral health maintenance.

Q: Is Astrexine known to affect sleep patterns?

The official documentation for the systemic form of this drug includes warnings about disturbances in the central nervous system. These documented effects may be reflected as a side effect known as trouble sleeping.

Q: Is Astrexine a controlled substance in the US or other countries?

Regulatory classifications define Astrexine as an Antiseptic and Antimicrobial Agent. Based on official records, the product is not listed as a controlled substance in standard drug scheduling databases.

Q: Is Astrexine prescribed for anxiety or only for [main use]? (Assume main use is depression)

Astrexine oral rinse is only indicated for the topical treatment of gingivitis. Its regulatory approval and classification are not for the treatment of psychiatric conditions like anxiety or depression.

Q: What if I start taking other supplements while on Astrexine?

Official documentation primarily addresses local interactions with anionic compounds found in other oral care products. Due to the drug's minimal systemic absorption, it is not expected to cause systemic interactions with most oral supplements.

Q: Can Astrexine be stopped suddenly, or does it need to be tapered?

The product is for short-term topical use and is poorly absorbed into the body. Official documentation for the oral rinse does not contain instructions for tapering the dose.

Q: What is the generally accepted duration of treatment with Astrexine?

Official documentation specifies that the use of Astrexine is intended to be short-term. If a patient requires continued use, they must undergo professional reevaluation at intervals not longer than six months to assess the ongoing necessity of the application.

Q: Why is Astrexine sometimes prescribed in combination with other drugs?

Astrexine is classified as an antimicrobial agent that is prescribed to chemically control the microbial environment in the oral cavity. Combination use with other treatments is sometimes employed to facilitate comprehensive management of various oral health issues.

Q: Are there any known issues with taking Astrexine before a surgery?

The official administration protocol mandates that the use of the rinse must be initiated following a dental prophylaxis (professional cleaning).

Q: What should be done if a person experiences an allergic reaction to Astrexine?

Official regulatory guidance states that users should immediately stop using the product and seek emergency medical attention if they experience symptoms of a serious allergic reaction, such as facial swelling, hives, or breathing difficulty.

Q: Can Astrexine cause changes in appetite?

While a change in appetite is not explicitly listed as a side effect, the official documentation does list common side effects that include an alteration in taste perception and gastrointestinal issues, both of which may influence eating habits.

Q: Is there any research evidence on Astrexine's use in children or adolescents?

The rinse is officially approved for use in individuals aged 6 years and older. Its use is explicitly not recommended in children under 6 due to concerns regarding the inability to reliably control the swallowing of the rinse.

Q: Does Astrexine affect or interfere with birth control pills?

Due to the drug's minimal systemic absorption from the oral rinse, it is not expected to interfere with systemic medications like hormonal birth control pills.

Q: What is the maximum amount of time Astrexine has been studied for continuous use?

Official usage guidelines stipulate that patients requiring continued use must be reevaluated by a professional at intervals not longer than six months to determine if further application is necessary. Research has tracked some participants over longer periods, but the regulatory requirement for reevaluation every six months remains key.

Q: Does the time of day I take Astrexine matter?

The standard dosing frequency is set for twice daily, typically morning and evening. Official instructions also advise against eating or drinking immediately after use, which suggests the rinse should be timed around major meals to preserve its local effect.

Q: Are there any food restrictions while using Astrexine?

Official instructions restrict the consumption of food or beverages immediately following use. This measure is documented to preserve the duration of the drug's local effect in the mouth.

Q: What kind of monitoring is typically recommended for patients taking Astrexine?

Patients are typically advised to see their dental professional at least every six months for dental cleanings. This monitoring allows for a professional reevaluation to assess the necessity of continued application and to remove any potential staining or calculus.

How should Astrexine be stored and disposed of?

Astrexine Oral Rinse Solution must be stored according to specific environmental and temperature controls defined in regulatory labeling.

Official Storage Conditions

Condition Requirement
Temperature Store at controlled room temperature (20 C–25 C).
Protection Must be protected from light and moisture.
Prohibited Do not freeze the solution; do not store in the bathroom.
Packaging Keep in the original container, tightly closed.
Child Safety Keep out of the sight and reach of children.

Disposal of unused or expired Astrexine must follow local pharmaceutical waste regulations. The official preferred method is to utilize a drug take-back program. Disposal guidance restricts pouring the solution into drains or wastewater systems. If a take-back program is unavailable, the product may be mixed with an undesirable substance (like dirt) and sealed for household trash disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Astrexine found in:

A-Z Index: